The global Legionella testing market is on the brink of significant expansion, with forecasts predicting a surge in market valuation from USD 355.1 million in 2024 to a remarkable USD 910 million by 2034. This robust growth represents a Compound Annual Growth Rate (CAGR) of 9.9%.
The anticipated market growth reflects a growing recognition of Legionnaires’ disease, a severe pneumonia caused by Legionella bacteria, and the critical need for effective detection and mitigation strategies. As awareness of the disease’s serious health risks increases, so does the demand for advanced testing solutions to ensure prompt and accurate identification of the bacteria.
Checkout Now to Access Market Intelligence
Regulatory mandates across various sectors, including healthcare, hospitality, and industrial industries, are further bolstering the demand for comprehensive legionella testing services. These regulations underscore the importance of proactive measures to ensure public safety and compliance, thereby fueling market expansion.
As the legionella testing market continues to evolve, stakeholders are keenly focused on innovative solutions and technologies to enhance detection accuracy and efficiency. The anticipated growth underscores the critical importance of these advancements in safeguarding public health and meeting stringent regulatory standards.
Key Takeaways from the Market Study:
- Under type, the urine antigen testing (UAT) registered to expand at 9.7% CAGR by 2034.
- The United Kingdom is estimated to register at a CAGR of 11.1% by 2034.
- China experiences significant growth, projected at a CAGR of 10.5% by 2034.
- Based on end user, the clinical laboratories segment is anticipated to expand at 9.5% CAGR by 2034.
“The growth in awareness of Legionnaires’ disease and the need for effective risk management strategies is one significant driver for the Legionella Testing market,” comments a Future Market Insights analyst.
Competitive Landscape:
Established players offer a wide a range of testing services and solutions Innovative startups have started leveraging technological advancements to disrupt traditional testing methods.
Competition is majorly fueled by factors such as regulatory compliance, technological innovation, and customer-centricity. Some of the key developments are:
- In December 2021, Pace Analytical Services acquired Special Pathogens Laboratory, a specialist used in Legionella testing, detection, remediation, and prevention.
- In April 2018, Phigenics Research and Innovation Lab introduced the Next Day Legionella PCR test, that leveraged the patented Phigenics Validation Test (PVT) TimeZero method required for rapid detection of Legionella DNA via PCR.
Elevate Your Strategy with Full Report Access – Get It Now
Key Companies Profiled:
- Quidel Corporation
- Abbott (Alere)
- Merck KGaA
- Bio-Rad Laboratories Inc.
- Thermo Fisher Scientific Inc.
- Pro-lab Diagnostics Inc.
- bioMerieux
- IDEXX Corporation
- Eurofins Scientific
- Beckman Coulter Inc.
Key Segments:
By Type:
- Culture Media
- Urine Antigen Testing (UAT)
- Polymerase Chain Reaction (PCR)
- Serology
- Direct Fluorescent Antibody (DFA) Test
By End User:
- Hospitals & Clinics
- Clinical Laboratories
- Others
By Region:
- North America
- Latin America
- Western Europe
- Eastern Europe
- South Asia and Pacific
- East Asia
- Middle East and Africa
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube